177 related articles for article (PubMed ID: 30381824)
1. Detection of circulating microRNAs with Ago2 complexes to monitor the tumor dynamics of colorectal cancer patients during chemotherapy.
Fuji T; Umeda Y; Nyuya A; Taniguchi F; Kawai T; Yasui K; Toshima T; Yoshida K; Fujiwara T; Goel A; Nagasaka T
Int J Cancer; 2019 May; 144(9):2169-2180. PubMed ID: 30381824
[TBL] [Abstract][Full Text] [Related]
2. Serum miR-200c is a novel prognostic and metastasis-predictive biomarker in patients with colorectal cancer.
Toiyama Y; Hur K; Tanaka K; Inoue Y; Kusunoki M; Boland CR; Goel A
Ann Surg; 2014 Apr; 259(4):735-43. PubMed ID: 23982750
[TBL] [Abstract][Full Text] [Related]
3. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer.
Imaoka H; Toiyama Y; Fujikawa H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Toden S; Goel A; Kusunoki M
Ann Oncol; 2016 Oct; 27(10):1879-86. PubMed ID: 27502702
[TBL] [Abstract][Full Text] [Related]
4. Extracellular microRNAs in human circulation are associated with miRISC complexes that are accessible to anti-AGO2 antibody and can bind target mimic oligonucleotides.
Geekiyanage H; Rayatpisheh S; Wohlschlegel JA; Brown R; Ambros V
Proc Natl Acad Sci U S A; 2020 Sep; 117(39):24213-24223. PubMed ID: 32929008
[TBL] [Abstract][Full Text] [Related]
5. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Circulating miRNAs Expression Alterations in Matched Tissue and Plasma Samples During Colorectal Cancer Progression.
Nagy ZB; Barták BK; Kalmár A; Galamb O; Wichmann B; Dank M; Igaz P; Tulassay Z; Molnár B
Pathol Oncol Res; 2019 Jan; 25(1):97-105. PubMed ID: 28980150
[TBL] [Abstract][Full Text] [Related]
7. microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers.
Brunet Vega A; Pericay C; Moya I; Ferrer A; Dotor E; Pisa A; Casalots À; Serra-Aracil X; Oliva JC; Ruiz A; Saigí E
Oncol Rep; 2013 Jul; 30(1):320-6. PubMed ID: 23673725
[TBL] [Abstract][Full Text] [Related]
8. A panel of six-circulating miRNA signature in serum and its potential diagnostic value in colorectal cancer.
Maminezhad H; Ghanadian S; Pakravan K; Razmara E; Rouhollah F; Mossahebi-Mohammadi M; Babashah S
Life Sci; 2020 Oct; 258():118226. PubMed ID: 32771555
[TBL] [Abstract][Full Text] [Related]
9. Serum microRNA-29a is a promising novel marker for early detection of colorectal liver metastasis.
Wang LG; Gu J
Cancer Epidemiol; 2012 Feb; 36(1):e61-7. PubMed ID: 22018950
[TBL] [Abstract][Full Text] [Related]
10. Circulating microRNA-762 upregulation in colorectal cancer may be accompanied by Wnt-1/β-catenin signaling.
Lai PS; Chang WM; Chen YY; Lin YF; Liao HF; Chen CY
Cancer Biomark; 2021; 32(2):111-122. PubMed ID: 34092606
[TBL] [Abstract][Full Text] [Related]
11. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma.
Arroyo JD; Chevillet JR; Kroh EM; Ruf IK; Pritchard CC; Gibson DF; Mitchell PS; Bennett CF; Pogosova-Agadjanyan EL; Stirewalt DL; Tait JF; Tewari M
Proc Natl Acad Sci U S A; 2011 Mar; 108(12):5003-8. PubMed ID: 21383194
[TBL] [Abstract][Full Text] [Related]
12. Examining plasma microRNA markers for colorectal cancer at different stages.
Sun Y; Liu Y; Cogdell D; Calin GA; Sun B; Kopetz S; Hamilton SR; Zhang W
Oncotarget; 2016 Mar; 7(10):11434-49. PubMed ID: 26863633
[TBL] [Abstract][Full Text] [Related]
13. Circulating Exosomal MicroRNA-21 as a Biomarker in Each Tumor Stage of Colorectal Cancer.
Tsukamoto M; Iinuma H; Yagi T; Matsuda K; Hashiguchi Y
Oncology; 2017; 92(6):360-370. PubMed ID: 28376502
[TBL] [Abstract][Full Text] [Related]
14. [The Efficiency of Immunoprecipitation of microRNA/Ago2 Complexes from Human Blood Plasma Is Protocol Dependent].
Panshin DD; Kondratov KA
Mol Biol (Mosk); 2020; 54(2):244-251. PubMed ID: 32392193
[TBL] [Abstract][Full Text] [Related]
15. Detection of circulating miRNAs: comparative analysis of extracellular vesicle-incorporated miRNAs and cell-free miRNAs in whole plasma of prostate cancer patients.
Endzeliņš E; Berger A; Melne V; Bajo-Santos C; Soboļevska K; Ābols A; Rodriguez M; Šantare D; Rudņickiha A; Lietuvietis V; Llorente A; Linē A
BMC Cancer; 2017 Nov; 17(1):730. PubMed ID: 29121858
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-223 and microRNA-92a in stool and plasma samples act as complementary biomarkers to increase colorectal cancer detection.
Chang PY; Chen CC; Chang YS; Tsai WS; You JF; Lin GP; Chen TW; Chen JS; Chan EC
Oncotarget; 2016 Mar; 7(9):10663-75. PubMed ID: 26848774
[TBL] [Abstract][Full Text] [Related]
17. MiR-4435 is an UQCRB-related circulating miRNA in human colorectal cancer.
Hong JW; Kim JM; Kim JE; Cho H; Kim D; Kim W; Oh JW; Kwon HJ
Sci Rep; 2020 Feb; 10(1):2833. PubMed ID: 32071343
[TBL] [Abstract][Full Text] [Related]
18. Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer.
Wang Q; Huang Z; Ni S; Xiao X; Xu Q; Wang L; Huang D; Tan C; Sheng W; Du X
PLoS One; 2012; 7(9):e44398. PubMed ID: 22970209
[TBL] [Abstract][Full Text] [Related]
19. Colorectal cancer cell-derived extracellular vesicles transfer miR-221-3p to promote endothelial cell angiogenesis via targeting suppressor of cytokine signaling 3.
Dokhanchi M; Pakravan K; Zareian S; Hussen BM; Farid M; Razmara E; Mossahebi-Mohammadi M; Cho WC; Babashah S
Life Sci; 2021 Nov; 285():119937. PubMed ID: 34508764
[TBL] [Abstract][Full Text] [Related]
20. The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer.
Chen WY; Zhao XJ; Yu ZF; Hu FL; Liu YP; Cui BB; Dong XS; Zhao YS
Int J Clin Exp Pathol; 2015; 8(6):7092-101. PubMed ID: 26261602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
